|Breast cancer classification and prognosis based on gene expression profiles from a population-based study|
C Sotiriou, SY Neo, LM McShane, EL Korn, PM Long, A Jazaeri, P Martiat, ...
Proceedings of the National Academy of Sciences 100 (18), 10393-10398, 2003
|Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis|
C Sotiriou, P Wirapati, S Loi, A Harris, S Fox, J Smeds, H Nordgren, ...
Journal of the National Cancer Institute 98 (4), 262-272, 2006
|Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers|
E Lim, F Vaillant, D Wu, NC Forrest, B Pal, AH Hart, ML Asselin-Labat, ...
Nature medicine 15 (8), 907-913, 2009
|Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study|
DR Camidge, YJ Bang, EL Kwak, AJ Iafrate, M Varella-Garcia, SB Fox, ...
The lancet oncology 13 (10), 1011-1019, 2012
|Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome|
RW Tothill, AV Tinker, J George, R Brown, SB Fox, S Lade, DS Johnson, ...
Clinical cancer research 14 (16), 5198-5208, 2008
|Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse|
GJ Bates, SB Fox, C Han, RD Leek, JF Garcia, AL Harris, AH Banham
Journal of Clinical Oncology 24 (34), 5373-5380, 2006
|Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor β-1, platelet-derived endothelial …|
M Relf, S LeJeune, PAE Scott, S Fox, K Smith, R Leek, A Moghaddam, ...
Cancer research 57 (5), 963-969, 1997
|BRCA mutation frequency and patterns of treatment response in BRCA mutation–positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group|
K Alsop, S Fereday, C Meldrum, A DeFazio, C Emmanuel, J George, ...
Journal of Clinical Oncology 30 (21), 2654, 2012
|Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation|
PB Vermeulen, G Gasparini, SB Fox, M Toi, L Martin, P McCulloch, ...
European Journal of Cancer 32 (14), 2474-2484, 1996
|Breast cancer prognostic classification in the molecular era: the role of histological grade|
EA Rakha, JS Reis-Filho, F Baehner, DJ Dabbs, T Decker, V Eusebi, ...
Breast Cancer Research 12 (4), 1-12, 2010
|Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial|
D Rischin, RJ Young, R Fisher, SB Fox, QT Le, LJ Peters, B Solomon, ...
Journal of clinical oncology 28 (27), 4142, 2010
|Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists|
S Badve, DJ Dabbs, SJ Schnitt, FL Baehner, T Decker, V Eusebi, SB Fox, ...
Modern Pathology 24 (2), 157-167, 2011
|Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours|
PB Vermeulen, G Gasparini, SB Fox, C Colpaert, LP Marson, M Gion, ...
European journal of cancer 38 (12), 1564-1579, 2002
|Lymphangiogenesis and lymphatic vessel remodelling in cancer|
SA Stacker, SP Williams, T Karnezis, R Shayan, SB Fox, MG Achen
Nature Reviews Cancer 14 (3), 159-172, 2014
|Quantitation and prognostic value of breast cancer angiogenesis: comparison of microvessel density, Chalkley count, and computer image analysis|
SB Fox, RD Leek, MP Weekes, RM Whitehouse, KC Gatter, AL Harris
The Journal of pathology 177 (3), 275-283, 1995
|Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)|
N Mavaddat, D Barrowdale, IL Andrulis, SM Domchek, D Eccles, ...
Cancer Epidemiology and Prevention Biomarkers 21 (1), 134-147, 2012
|Thymidine phosphorylase is angiogenic and promotes tumor growth|
A Moghaddam, HT Zhang, TP Fan, DE Hu, VC Lees, H Turley, SB Fox, ...
Proceedings of the National Academy of Sciences 92 (4), 998-1002, 1995
|MET amplification identifies a small and aggressive subgroup of esophagogastric adenocarcinoma with evidence of responsiveness to crizotinib|
JK Lennerz, EL Kwak, A Ackerman, M Michael, SB Fox, K Bergethon, ...
Journal of clinical oncology 29 (36), 4803, 2011
|Normal human tissues, in addition to some tumors, express multiple different CD44 isoforms|
SB Fox, J Fawcett, DG Jackson, I Collins, KC Gatter, AL Harris, A Gearing, ...
Cancer research 54 (16), 4539-4546, 1994
|Non-small-cell lung carcinoma tumor growth without morphological evidence of neo-angiogenesis.|
F Pezzella, U Pastorino, E Tagliabue, S Andreola, G Sozzi, G Gasparini, ...
The American journal of pathology 151 (5), 1417, 1997